Jean‐Paul Fermand
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 48
- Multiple Myeloma Research and Treatments 42
- Hematopoietic Stem Cell Transplantation 9
- Genetics 22
- Chronic Lymphocytic Leukemia Research 15
- Co-authors
- Jean‐Claude BrouetBruno RoyerVéronique LeblondArnaud JaccardSylvie ChevretFrank BridouxPhilippe RavaudBertrand Arnulf
- Journals
- Blood (26 papers)Journal of the American Academy of Dermatology (5 papers)Medicine (5 papers)Kidney International (5 papers)British Journal of Haematology (4 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Jean‐Paul Fermand
102 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 99
- Hematology 1.8k
- Genetics 890
- Nephrology 410
- Oncology 1.4k
- Immunology 792
Countries citing papers authored by Jean‐Paul Fermand
This map shows the geographic impact of Jean‐Paul Fermand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Paul Fermand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Paul Fermand more than expected).
Fields of papers citing papers by Jean‐Paul Fermand
This network shows the impact of papers produced by Jean‐Paul Fermand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Paul Fermand. The network helps show where Jean‐Paul Fermand may publish in the future.
Co-authors
The 25 scholars most cited alongside Jean‐Paul Fermand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2017 | 1 | |
| 3 | 2016 | 9 | |
| 4 | 2013 | 9 | |
| 5 | 2013 | 1 | |
| 6 | 2012 | 20 | |
| 7 | 2011 | 2 | |
| 8 | 2011 | 0 | |
| 9 | 2010 | 96 | |
| 10 | 2009 | 56 | |
| 11 | 2009 | 156 | |
| 12 | 2009 | 81 | |
| 13 | 2008 | 54 | |
| 14 | 2002 | 6 | |
| 15 | Thalidomide et myélome : le renouveau d'un médicament décrié | 2001 | 1 |
| 16 | 2001 | 71 | |
| 17 | 2000 | 13 | |
| 18 | 1999 | 20 | |
| 19 | 1995 | 30 | |
| 20 | 1992 | 36 |
About Jean‐Paul Fermand
Jean‐Paul Fermand is a scholar working on Hematology, Genetics, Nephrology, Immunology and Oncology, having authored 105 papers that have together received 4.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (42 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (27 papers), Chronic Lymphocytic Leukemia Research (15 papers), T-cell and B-cell Immunology (9 papers), Renal Diseases and Glomerulopathies (9 papers), Hematopoietic Stem Cell Transplantation (9 papers), Protein Degradation and Inhibitors (8 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (890 citations), Nephrology (410 citations), Oncology (1.4k citations) and Immunology (792 citations). Jean‐Paul Fermand has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean‐Claude Brouet, Bruno Royer, Véronique Leblond, Arnaud Jaccard, Sylvie Chevret, Frank Bridoux, Philippe Ravaud, Bertrand Arnulf, Marine Diviné and Margaret Macro. Their work appears in journals such as Blood, Journal of the American Academy of Dermatology, Medicine, Kidney International and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.